ACN
54
2
WM
53
2
WBA
41
3
MET
58
2
CVX
25
14
DOW
47
4
GD
42
4
ABT
54
4
GWW
50
9
EFX
43
3
MSFT
55
2
EMN
40
5
T
32
2
HD
43
8
HPQ
55
3
HCP
54
2
EXPE
83
8
MKC
54
3
AKAM
50
2
NTRS
35
10
ACN
54
2
WM
53
2
WBA
41
3
MET
58
2
CVX
25
14
DOW
47
4
GD
42
4
ABT
54
4
GWW
50
9
EFX
43
3
MSFT
55
2
EMN
40
5
T
32
2
HD
43
8
HPQ
55
3
HCP
54
2
EXPE
83
8
MKC
54
3
AKAM
50
2
NTRS
35
10
Financhill
Back

Acumen Pharmaceuticals 10K Form

Sell
3

ABOS
Acumen Pharmaceuticals

Last Price:
$1.85
Seasonality Move:
-0.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ABOS News And Ratings

See the #1 stock for the next 7 days that we like better than ABOS

ABOS Financial Statistics

Sales & Book Value

Annual Sales: $1.4M
Cash Flow: $-24.6M
Price / Cash Flow: 0
Annual Sales: $3.62
Price / Book: 0.51

Profitability

EPS (TTM): -1.38000
Net Income (TTM): $-81.7M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Acumen Pharmaceuticals Earnings Forecast

Key Acumen Pharmaceuticals Financial Ratios

  • The Interest Expense is -1.11% of Operating Income.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Acumen Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ABOS
Website: acumenpharm.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ABOS Technical Analysis vs Fundamental Analysis

Sell
3
Acumen Pharmaceuticals (ABOS) is a Sell

Is Acumen Pharmaceuticals a Buy or a Sell?